System and method for tracking progression of left ventricular dysfunction using implantable cardiac stimulation device
US6922587B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Jun 26, 2002 |
| Grant date | Jul 26, 2005 |
| Priority date | — |
| Expiry date | May 14, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/3622
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The progression or regression of left ventricular dysfunction (LVD) is automatically evaluated by a pacemaker or other implantable cardiac stimulation device by tracking changes in the resting sinus rate of the patient in which the device is implanted. The resting sinus rate is detected by first determining whether the patient is in a state of profound rest, such as sleep, then measuring the actual sinus rate during profound rest. Profound rest may be detected by using an activity variance sensor. An increase in the profound rest sinus rate over a period of several months indicates progression of LVD; whereas a decrease indicates regression. Appropriate LVD diagnostic information is recorded for subsequent review by a physician. Based on the progression or regression of LVD, the physician may then modify LVD drug therapy administered to the patient or may adjust control parameters of the pacemaker, such as overdrive pacing control parameters or control parameters affecting heart contractility via post-extrasystolic potentiation. If a drug pump is implanted within the patient for automatically delivering LVD drug therapy, the pacemaker controls the drug pump in view of any detected …
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.